Biodexa Pharmaceuticals Announces A Ratio Change On Its ADRs From 1 ADS Representing 400 Ordinary Shares, To The New Ratio Of 1 ADR Representing 10,000 Ordinary Shares (1-For-25) ; Effective Date Of The Ratio Change Is Expected To Be October 4,2024.
Portfolio Pulse from Benzinga Newsdesk
Biodexa Pharmaceuticals (NASDAQ:BDRX) announced a change in the ratio of its ADRs from 1 ADR representing 400 ordinary shares to 1 ADR representing 10,000 ordinary shares, effective October 4, 2024. ADR holders must exchange their ADRs on a mandatory basis.
September 19, 2024 | 8:33 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Biodexa Pharmaceuticals is changing its ADR ratio from 1:400 to 1:10,000, effective October 4, 2024. This mandatory exchange may affect liquidity and trading dynamics of BDRX shares.
The ADR ratio change is a significant corporate action that will require ADR holders to exchange their shares. This could impact the liquidity and trading dynamics of BDRX shares, but the overall effect on the stock price is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100